Zenotech Laboratories declared their Q3 FY24 results on 29 Jan, 2024. The topline increased by 24.41% & the profit increased by 143.21% YoY. As compared to the previous quarter, the revenue declined by 5.08% and the profit increased by 18.58%.
The Selling, general & administrative expenses rose by 5.38% q-o-q & increased by 17.42% Y-o-Y.
The operating income was down by 5.04% q-o-q & increased by 99.13% Y-o-Y.
The EPS is ₹0.55 for Q3 FY24, which increased by 139.13% Y-o-Y.
Zenotech Laboratories has delivered -3.55% return in the last 1 week, 14.36% return in the last 6 months, and 8.95% YTD return.
Currently, Zenotech Laboratories has a market cap of ₹442.72 Cr and a 52wk high/low of ₹81 & ₹45 respectively.
Zenotech Laboratories Financials
Period | Q3 FY24 | Q2 FY24 | Q-o-Q Growth | Q3 FY23 | Y-o-Y Growth |
---|---|---|---|---|---|
Total Revenue | 10.94 | 11.53 | -5.08% | 8.8 | +24.41% |
Selling/ General/ Admin Expenses Total | 2.34 | 2.22 | +5.38% | 1.99 | +17.42% |
Depreciation/ Amortization | 1.74 | 1.81 | -3.46% | 1.8 | -3.35% |
Total Operating Expense | 7.42 | 7.82 | -5.1% | 7.03 | +5.62% |
Operating Income | 3.52 | 3.71 | -5.04% | 1.77 | +99.13% |
Net Income Before Taxes | 3.8 | 3.9 | -2.43% | 1.93 | +97.01% |
Net Income | 3.36 | 2.83 | +18.58% | 1.38 | +143.21% |
Diluted Normalized EPS | 0.55 | 0.46 | +19.57% | 0.23 | +139.13% |
Catch all the Business News , Corporate news , Breaking News Events and Latest News Updates on Live Mint. Download The Mint News App to get Daily Market Updates.